Table 1. Clinical manifestations of Lyme borreliosis, serology and exposure to ticks among tick bite cases with evidence of Borrelia infection within three months after a tick bite.
Case | Evidence of Borrelia infection | C6 ELISA index* | IgM immunoblot | IgG immunoblot | Borrelia in tick | Tick engorgement | hours of tick attachment | ||||
Clinical | Seroconversion** | 1st | 2nd | 1st | 2nd | 1st | 2nd | ||||
1 | yes (EM) | yes (IgG) | 1.12 | 0.83 | − | − | +/− | + | n.a. | n.a. | 30 |
2 | yes (EM) | yes (C6) | 0.21 | 1.90 | − | − | − | − | + (untypeable Borrelia) | full | 16 |
3 | yes (EM) | no | 0.49 | 0.52 | +/− | +/− | − | − | + (B. afzelii) | unengorged | 60 |
4 | yes (EM) | no | 0.27 | 0.37 | +/− | +/− | − | − | − | full | 36 |
5 | yes (EM) | no | 0.47 | 0.43 | − | − | − | − | n.a. | n.a. | 8 |
6 | yes (EM) | no | 0.64 | 0.98 | +/− | +/− | − | − | − | unengorged | 30 |
7 | yes (EM) | no | 0.37 | 0.33 | − | − | − | − | + (untypeable Borrelia) | partial | 15 |
8 | no | yes (C6 & IgM & IgG) | 0.40 | 3.79 | − | + | − | + | n.a. | n.a. | 26 |
9 | no | yes (C6) | 0.29 | 3.69 | +/− | +/− | − | − | n.a. | n.a. | 20 |
10 | no | yes (C6 & IgM) | 0.37 | 2.63 | − | + | − | +/− | n.a. | n.a. | 24 |
11 | no | yes (C6 & IgM) | 0.76 | 6.57 | +/− | + | − | +/− | + (untypeable Borrelia) | full | 20 |
12 | no | yes (C6) | 0.42 | 7.01 | − | +/− | − | +/− | − | partial | n.a. |
13 | no | yes (C6) | 0.22 | 1.86 | − | − | − | − | + (B. afzelii) | partial | n.a. |
14 | no | yes (C6 & IgG) | 0.26 | 5.84 | − | − | − | + | + (untypeable Borrelia) | partial | 72 |
15 ‡ | yes (neuroborreliosis) | no | 4.12 | 6.49 | + | + | + | + | − | Full | 36 |
EM = erythema migrans; n.a. = no tick available for testing.
C6 ELISA test results were scored as negative (ELISA index score, <0.90), borderline (0.90 to 1.09), or positive (≥1.10).
Seroconversion of IgM and/or IgG in the immunoblot and/or in the C6 ELISA was considered as evidence of an early Borrelia infection. For seroconversion in the C6 ELISA, the ELISA index score was required to be <1.10 in the baseline serum, and ≥1.10 in the consecutive serum, with a minimum increase of 1.5 points.
case #15 was excluded from risk analyses, as the development of Lyme borreliosis was almost certainly not attributable to the tick bite at baseline.